Warning: The NCBI web site requires JavaScript to function. more...
How close is the bench to the bedside? Metabolic profiling in cancer research.
Van QN, Veenstra TD.
Genome Med. 2009 Jan 20;1(1):5.
Related citations
Metabolomics: A Revolution for Novel Cancer Marker Identification.
Bu Q, Huang Y, Yan G, Cen X, Zhao YL.
Comb Chem High Throughput Screen. 2012 Jan 4. [Epub ahead of print]
Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC, Koh PK, Mal M, Cheah PY, Eu KW, Backshall A, Cavill R, Nicholson JK, Keun HC.
J Proteome Res. 2009 Jan;8(1):352-61.
Analytical and statistical approaches to metabolomics research.
Issaq HJ, Van QN, Waybright TJ, Muschik GM, Veenstra TD.
J Sep Sci. 2009 Jul;32(13):2183-99. Review.
Metabolomics of cancer.
Serkova NJ, Glunde K.
Methods Mol Biol. 2009;520:273-95.
The role of metabolic biomarkers in drug toxicity studies.
Schnackenberg LK, Beger RD.
Toxicol Mech Methods. 2008;18(4):301-11.
[Recent development of metabonomics and its applications in clinical research].
Li H, Jiang Y, He FC.
Yi Chuan. 2008 Apr;30(4):389-99. Review. Chinese.
Metabolomics: available results, current research projects in breast cancer, and future applications.
Claudino WM, Quattrone A, Biganzoli L, Pestrin M, Bertini I, Di Leo A.
J Clin Oncol. 2007 Jul 1;25(19):2840-6. Epub 2007 May 14. Review.
Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
Matta A, Ralhan R, DeSouza LV, Siu KW.
Mass Spectrom Rev. 2010 Nov-Dec;29(6):945-61. Review.
Quality control of herbal material and phytopharmaceuticals with MS and NMR based metabolic fingerprinting.
van der Kooy F, Maltese F, Choi YH, Kim HK, Verpoorte R.
Planta Med. 2009 Jun;75(7):763-75. Epub 2009 Mar 13. Review.
Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes.
Lanza IR, Zhang S, Ward LE, Karakelides H, Raftery D, Nair KS.
PLoS One. 2010 May 10;5(5):e10538.
Comparative metabolomics of breast cancer.
Yang C, Richardson AD, Smith JW, Osterman A.
Pac Symp Biocomput. 2007:181-92.
Applications of liquid chromatography coupled to mass spectrometry-based metabolomics in clinical chemistry and toxicology: A review.
Roux A, Lison D, Junot C, Heilier JF.
Clin Biochem. 2011 Jan;44(1):119-35. Epub 2010 Aug 26. Review.
Challenges and developments in tandem mass spectrometry based clinical metabolomics.
Ceglarek U, Leichtle A, Brügel M, Kortz L, Brauer R, Bresler K, Thiery J, Fiedler GM.
Mol Cell Endocrinol. 2009 Mar 25;301(1-2):266-71. Epub 2008 Oct 19.
Application of metabonomics in drug development.
Keun HC, Athersuch TJ.
Pharmacogenomics. 2007 Jul;8(7):731-41. Review.
[Progress in nuclear magnetic resonance spectroscopy for early cancer diagnosis].
Gao XX, Xu YZ, Zhao MX, Qi J, Li HZ, Wu JG.
Guang Pu Xue Yu Guang Pu Fen Xi. 2008 Aug;28(8):1942-50. Review. Chinese.
Challenges in applying chemometrics to LC-MS-based global metabolite profile data.
Want E.
Bioanalysis. 2009 Jul;1(4):805-19. Review.
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
Metabonomics investigation of human urine after ingestion of green tea with gas chromatography/mass spectrometry, liquid chromatography/mass spectrometry and (1)H NMR spectroscopy.
Law WS, Huang PY, Ong ES, Ong CN, Li SF, Pasikanti KK, Chan EC.
Rapid Commun Mass Spectrom. 2008 Aug;22(16):2436-46.
Combining nuclear magnetic resonance spectroscopy and mass spectrometry in biomarker discovery.
Gowda GA, Ijare OB, Shanaiah N, Bezabeh T.
Biomark Med. 2009 Jun;3(3):307-22.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on